BERNARDI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 23.039
EU - Europa 6.421
AS - Asia 3.543
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 12
AF - Africa 6
Totale 33.059
Nazione #
US - Stati Uniti d'America 22.999
CN - Cina 2.312
UA - Ucraina 1.642
IT - Italia 1.217
DE - Germania 1.177
TR - Turchia 1.009
GB - Regno Unito 656
SE - Svezia 422
PL - Polonia 409
FI - Finlandia 361
BE - Belgio 259
FR - Francia 68
RU - Federazione Russa 59
HK - Hong Kong 50
VN - Vietnam 45
NL - Olanda 39
CA - Canada 36
IR - Iran 36
IN - India 32
AU - Australia 18
JP - Giappone 16
RO - Romania 15
CH - Svizzera 14
IE - Irlanda 13
AT - Austria 12
EU - Europa 12
CZ - Repubblica Ceca 11
ES - Italia 8
GR - Grecia 7
KR - Corea 7
NZ - Nuova Zelanda 6
PE - Perù 6
DK - Danimarca 5
GE - Georgia 5
NO - Norvegia 5
TW - Taiwan 5
BG - Bulgaria 4
BR - Brasile 4
IL - Israele 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
HU - Ungheria 3
ID - Indonesia 3
MX - Messico 3
PK - Pakistan 3
SG - Singapore 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DZ - Algeria 2
KE - Kenya 2
MK - Macedonia 2
MY - Malesia 2
TH - Thailandia 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BY - Bielorussia 1
HN - Honduras 1
IQ - Iraq 1
JO - Giordania 1
LU - Lussemburgo 1
MA - Marocco 1
MT - Malta 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 33.059
Città #
Woodbridge 2.987
Fairfield 2.928
Chandler 1.929
Houston 1.868
Jacksonville 1.835
Ashburn 1.409
Ann Arbor 1.407
Seattle 1.174
Wilmington 1.105
Cambridge 962
Izmir 629
Nanjing 570
Princeton 436
Ferrara 430
Warsaw 407
Beijing 383
New York 323
San Diego 269
Boardman 262
Brussels 250
Milan 181
Dearborn 173
Nanchang 171
Shenyang 169
Bremen 162
Shanghai 141
Hebei 120
Jiaxing 110
Tianjin 105
Falls Church 104
Changsha 91
Redwood City 86
Jinan 81
Norwalk 72
San Mateo 71
Kunming 66
Mountain View 65
London 53
Düsseldorf 51
Auburn Hills 49
Zhengzhou 45
Dong Ket 44
Addison 42
Des Moines 41
Hong Kong 40
Guangzhou 37
Ningbo 37
Orange 31
Rome 31
Helsinki 27
Taizhou 27
Hangzhou 26
Washington 26
Verona 25
Munich 23
Augusta 22
Los Angeles 22
Leawood 21
Philadelphia 21
Chicago 20
Bologna 19
Indiana 19
Monmouth Junction 19
Redmond 18
Toronto 17
Hanover 16
Ardabil 15
Fuzhou 14
Hefei 13
Mcallen 13
Padova 13
Lanzhou 12
Tappahannock 12
Hounslow 11
Brno 10
Haikou 10
Montréal 10
Napoli 10
Vienna 10
Piemonte 9
Changchun 8
Paris 8
Acton 7
Andover 7
Ferrara di Monte Baldo 7
Kilburn 7
Pavia 7
San Francisco 7
Taiyuan 7
Wuhan 7
Abdullah 6
Chengdu 6
Dublin 6
Florence 6
Walnut 6
Chiswick 5
Malo 5
Melbourne 5
Minerbio 5
Rochester 5
Totale 24.689
Nome #
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 303
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 208
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 188
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 182
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 182
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 169
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 167
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 162
Moderate alcohol intake and hemostatic and inflammatory markers in middle-aged women: a controlled study 155
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 154
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 151
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 148
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 148
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 141
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 141
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 141
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 140
Hemostasis biomarkers in multiple sclerosis 140
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 139
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 138
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 133
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus? 133
Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein of 18q22.3 133
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 132
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 128
Chronic sleep deprivation markedly reduces coagulation factor VII expression 127
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 127
null 125
The dominant-negative von Willebrand factor gene deletion p.P1127-C1948delinsR: Molecular mechanism and modulation 124
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 123
Characterization of a deleted Y chromosome in a male with Turner stigmata 123
null 121
Taqi polymorphism at the human coagulation factor XII locus (F12) 120
Circadian rhythms in mouse blood coagulation 119
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 119
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 119
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 118
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 118
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 118
Plasma levels of soluble NCAM in multiple sclerosis 117
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 117
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 116
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 116
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 116
Better or worse than the original 116
A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates. 115
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 115
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 114
Major differences in bleeding symptoms between factor VII deficiency and hemophilia B 113
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 113
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 113
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 112
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease. 112
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 112
A NEW DISEASE-CAUSING MUTATION IN THE GAP-RELATED DOMAIN OF THE NF1 GENE 111
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 111
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations 111
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 111
Temporal variations of coagulation factor VII activity in mice are influenced by lighting regime 110
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. 110
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 110
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects 110
null 109
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 109
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia 109
Membrane binding and anticoagulant properties of protein S natural variants 109
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 109
Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser) 108
Partial gene deletion in a family with factor X deficiency 108
Detection and characterization of polymorphic markers in the factor-VII gene. 107
PvuII RFLP inside the human estrogen receptor gene 107
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 106
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 106
Rescue of coagulation factor VII function by the U1+5A snRNA 106
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 105
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 105
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 105
RNA-based therapeutic approaches for coagulation factor deficiencies 104
null 103
Factor IX propeptide mutation and life threatening bleeding 103
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis 103
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 103
Phytochemical Analysis and Cytotoxicity Towards Multidrug-Resistant Leukemia Cells of Essential Oils Derived from Lebanese Medicinal Plants 103
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 103
Assignment of human coagulation factor XII (fXII) to chromosome 5 by cDNA hybridization to DNA from somatic cell hybrids 102
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 102
Factor VII mutant V154G models a zymogen-like form of factor VIIa 102
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 102
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 102
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 102
Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency 102
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 102
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 101
A unique exon specific U1snRNA rescues different haemophilia B - causing splicing-defective factor IX variants in mice 101
null 100
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 100
Functional properties of factor V and factor Va encoded by the R2-gene 100
Polymorphic changes in the 5' flanking region of factor VII have a combined effect on promoter strength 100
null 100
An underestimated combination of opposites resulting in enhanced thrombotic tendency 99
Totale 12.205
Categoria #
all - tutte 116.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 635
Totale 117.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.630 0 0 0 0 0 0 0 0 411 760 833 1.626
2019/20207.478 1.270 242 262 1.057 489 918 679 742 579 797 291 152
2020/20215.461 458 420 291 642 185 500 331 627 180 801 735 291
2021/20224.434 245 482 276 246 261 178 206 211 138 344 391 1.456
2022/20234.554 488 342 109 583 726 661 234 365 546 73 283 144
2023/20241.681 232 316 114 106 203 433 65 154 58 0 0 0
Totale 33.717